PROGNOSTIC IMPORTANCE OF INCREASED PLASMA AMINO-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE LEVELS IN A LARGE NONCARDIAC, GENERAL INTENSIVE CARE UNIT POPULATION

被引:41
作者
Kotanidou, Anastasia [1 ]
Karsaliakos, Petros [1 ]
Tzanela, Marinella [2 ]
Mavrou, Irini [3 ]
Kopterides, Petros [3 ]
Papadomichelakis, Evangelos [3 ]
Theodorakopoulou, Maria [3 ]
Botoula, Efi [2 ]
Tsangaris, Iralklis [3 ]
Lignos, Michalis [3 ]
Ikonomidis, Ignatios [4 ]
Ilias, Ioannis [5 ]
Armaganidis, Apostolos [3 ]
Ortanos, Stylianos E. [3 ]
Dimopoulou, Ioanna [3 ]
机构
[1] Univ Athens, Dept Crit Care Med 1, Athens, Greece
[2] Univ Athens, Evangelismos Hosp, Dept Endocrinol, Athens, Greece
[3] Univ Athens, Dept Crit Care Med 2, Athens, Greece
[4] Univ Athens, Attikon Hosp, Dept Cardiol 2, Athens, Greece
[5] Univ Athens, Sch Med, Elena Venizelou Hosp, Dept Endocrinol, GR-11527 Athens, Greece
来源
SHOCK | 2009年 / 31卷 / 04期
关键词
Critical illness; B-type natriuretic peptide; cytokines; organ dysfunction; prognosis; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; SEVERE SEPSIS; HEART-FAILURE; MYOCARDIAL DYSFUNCTION; CARDIAC DYSFUNCTION; RESPIRATORY-FAILURE; APACHE-II; MARKER; DISEASE;
D O I
10.1097/SHK.0b013e31818635b6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The present study aimed to determine whether amino-terminal pro-brain natriuretic peptide (NT-pro-BNP) predicts intensive care unit (ICU) mortality in a cohort of general, noncardiac, critically ill patients. To this end, a total of 233 consecutive mechanically ventilated patients (109 men) having a median age of 60 years and a wide range in admitting diagnoses, including medical (n = 118), surgical (n = 83), and multiple trauma (n = 32) cases were prospectively studied. Median Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment scores on ICU admission were 16 and 9, respectively. The study end point was ICU outcome. Blood samples were drawn on admission in the ICU and on postadmission days 1 and 2 to determine NT-pro-BNP levels. In a subgroup (n = 77), admission proinflammatory and anti-inflammatory cytokine levels, including TNF-alpha, IL-6, and IL-10, were also measured. Nonsurvivors (n = 98) had significantly higher NT-pro-BNP levels than survivors (n = 135) on admission in the ICU (2,074 vs. 283 pg/mL; P < 0.001), on day 1 (2,197 vs. 221 pg/mL; P < 0.001), and on day 2 (2,726 vs. 139 pg/mL; P < 0.001). Median values for TNF-alpha, IL-6, and IL-10 were 3.70, 131.57, and 111.88 pg/mL, respectively. Receiver operating characteristic analysis showed that the area under the receiver operating characteristic curve in predicting ICU mortality was 0.70 for APACHE 11 and 0.77 for admission NT-pro-BNP (P = 0.08). The cutoff in admission NT-pro-BNP that best predicted outcome was 941 pg/mL. Multiple logistic regression analysis revealed that APACHE 11 score (odds ratio, 1.06; P = 0.007) and the best cutoff point in admission NT-pro-BNP (odds ratio, 7.74; P < 0.001) independently predicted ICU mortality, even if cytokines were entered in the analysis. In conclusion, plasma NT-pro-BNP is frequently raised in noncardiac, mixed, critically ill patients, and nonsurvivors have consistently higher levels than survivors. Elevated admission NT-pro-BNP represents an independent predictor for poor ICU outcome in the presence of clinical severity scores.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 37 条
[1]   Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients [J].
Almog, Yaniv ;
Novack, Victor ;
Megralishvili, Rinat ;
Kobal, Sergio ;
Barski, Leonid ;
King, Daniel ;
Zahger, Doron .
ANESTHESIA AND ANALGESIA, 2006, 102 (06) :1809-1815
[2]   Differential secretion of atrial and brain natriuretic peptide in critically ill patients [J].
Berendes, E ;
Van Aken, H ;
Raufhake, C ;
Schmidt, C ;
Assmann, G ;
Walter, M .
ANESTHESIA AND ANALGESIA, 2001, 93 (03) :676-682
[3]   Natriuretic peptides, respiratory disease, and the right heart [J].
Bin Yap, L ;
Mukejee, D ;
Timms, PM ;
Ashrafian, H ;
Coghlan, JG .
CHEST, 2004, 126 (04) :1330-1336
[4]   Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis [J].
Brueckmann, M ;
Huhle, G ;
Lang, S ;
Haase, KK ;
Bertsch, T ;
Weiss, C ;
Kaden, JJ ;
Putensen, C ;
Borggrefe, M ;
Hoffmann, U .
CIRCULATION, 2005, 112 (04) :527-534
[5]   Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions [J].
Burke, Michael A. ;
Cotts, William G. .
HEART FAILURE REVIEWS, 2007, 12 (01) :23-36
[6]   Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis [J].
Charpentier, J ;
Luyt, CE ;
Fulla, Y ;
Vinsonneau, C ;
Cariou, A ;
Grabar, S ;
Dhainaut, JF ;
Mira, JP ;
Chiche, JD .
CRITICAL CARE MEDICINE, 2004, 32 (03) :660-665
[7]   Marked elevations in N-terminal brain natriuretic peptide levels in septic shock [J].
Chua, G ;
Lee, KH .
CRITICAL CARE, 2004, 8 (04) :R248-R250
[8]   B-Type natriuretic peptide and the prediction of outcome in patients admitted to intensive care [J].
Cuthbertson, BH ;
Patel, RR ;
Croal, BL ;
Barclay, J ;
Hillis, GS .
ANAESTHESIA, 2005, 60 (01) :16-21
[9]   B-type natriuretic peptide in cardiovascular disease [J].
de Lemos, JA ;
McGuire, DK ;
Drazner, MH .
LANCET, 2003, 362 (9380) :316-322
[10]   Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit [J].
Forfia, PR ;
Watkins, SP ;
Rame, JE ;
Stewart, KJ ;
Shapiro, EP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1667-1671